Related references
Note: Only part of the references are listed.Liver-directed chemotherapy of cetuximab and bevacizumab in combination with oxaliplatin is more effective to inhibit tumor growth of CC531 colorectal rat liver metastases than systemic chemotherapy
Jens Sperling et al.
CLINICAL & EXPERIMENTAL METASTASIS (2013)
Inhibition of PI3K/AKT/mTOR Pathway Enhances Temozolomide-Induced Cytotoxicity in Pituitary Adenoma Cell Lines in Vitro and Xenografted Pituitary Adenoma in Female Nude Mice
Congxin Dai et al.
ENDOCRINOLOGY (2013)
Inhibition of autophagy enhances anticancer effects of bevacizumab in hepatocarcinoma
Xian-ling Guo et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2013)
Tumor angiogenesis and anti-angiogenic therapy in malignant gliomas revisited
Karl H. Plate et al.
ACTA NEUROPATHOLOGICA (2012)
Hepatic arterial infusion of bevacizumab in combination with oxaliplatin reduces tumor growth in a rat model of colorectal liver metastases
Jens Sperling et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy
Chien-Ju Lin et al.
FREE RADICAL BIOLOGY AND MEDICINE (2012)
Prospective Study of Bevacizumab Plus Temozolomide in Patients With Advanced Neuroendocrine Tumors
Jennifer A. Chan et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Hypoxia-specific VEGF-expressing neural stem cells in spinal cord injury model
Jin Soo Oh et al.
NEUROREPORT (2012)
Inhibition of Mitochondria- and Endoplasmic Reticulum Stress-Mediated Autophagy Augments Temozolomide-Induced Apoptosis in Glioma Cells
Chien-Ju Lin et al.
PLOS ONE (2012)
Prognostic Factors and Survival in Primary Malignant Astrocytomas of the Spinal Cord A Population-Based Analysis From 1973 to 2007
Hadie Adams et al.
SPINE (2012)
A Combined Preclinical Therapy of Cannabinoids and Temozolomide against Glioma
Sofia Torres et al.
MOLECULAR CANCER THERAPEUTICS (2011)
The paradoxical effect of bevacizumab in the therapy of malignant gliomas
Eric M. Thompson et al.
NEUROLOGY (2011)
Bevacizumab for the Treatment of Recurrent Glioblastoma
Marc C. Chamberlain
CLINICAL MEDICINE INSIGHTS-ONCOLOGY (2011)
The inhibitory effect of different concentrations of topical bevacizumab on corneal neovascularization
Zohar Habot-Wilner et al.
ACTA OPHTHALMOLOGICA (2010)
Temozolomide/PLGA microparticles plus vatalanib inhibits tumor growth and angiogenesis in an orthotopic glioma model
Yu-Hui Zhang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Temozolomide Treatment for Aggressive Pituitary Tumors: Correlation of Clinical Outcome with O6-Methylguanine Methyltransferase (MGMT) Promoter Methylation and Expression
Zachary M. Bush et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
The Brain Tumor Window Model: A Combined Cranial Window and Implanted Glioma Model for Evaluating Intraoperative Contrast Agents
Daniel A. Orringer et al.
NEUROSURGERY (2010)
The Neuropharmacokinetics of Temozolomide in Patients with Resectable Brain Tumors: Potential Implications for the Current Approach to Chemoradiation
Jana Portnow et al.
CLINICAL CANCER RESEARCH (2009)
Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection
Umar Akbar et al.
JOURNAL OF NEURO-ONCOLOGY (2009)
Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme
Matthew J. McGirt et al.
JOURNAL OF NEUROSURGERY (2009)
Inhibition of corneal neovascularization by subconjunctival bevacizumab in an animal model
Miltiadis Papathanassiou et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2008)
Molecular predictors in glioblastoma - Toward personalized therapy
Howard Colman et al.
ARCHIVES OF NEUROLOGY (2008)
Conventional and gene therapy strategies for the treatment of brain tumors
J. A. Benitez et al.
CURRENT MEDICINAL CHEMISTRY (2008)
Malignant gliomas in adults
Patrick Y. Wen et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells
T Kanzawa et al.
CELL DEATH AND DIFFERENTIATION (2004)
Spinal cord and intradural-extraparenchymal spinal tumors: current best care practices and strategies
AT Parsa et al.
JOURNAL OF NEURO-ONCOLOGY (2004)
Promising survival for patients with newly diagnosed glioblastoma multiforme treated with concomitant radiation plus temozolomide followed by adjuvant temozolomide
R Stupp et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Treatment of refractory recurrent malignant glioma with adoptive cellular immunotherapy: a case report
YW Huang et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2001)
Adoptive cellular immunotherapy for the treatment of malignant gliomas
RL Hayes et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2001)
Malignant glioma: genetics and biology of a grave matter
EA Maher et al.
GENES & DEVELOPMENT (2001)
Share Paper
